North America Sterile Compounding Pharmacies Market
The North America Sterile Compounding Pharmacies Market size was valued at US$ 1,997.45 Mn in 2021 and is projected to reach US$ 3,218.93 Mn by 2028, growing at a CAGR of 7.1% during 2021 - 2028.
Report Coverage
- Product: Injectable Drugs and Infusions
- Route of Administration: Intravenous, Intramuscular, Subcutaneous
US$ 1,997.45 Mn
Market size in 2021
US$ 3,218.93 Mn
Market Size by 2028
7.1%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Sterile Compounding Pharmacies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Sterile Compounding Pharmacies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Sterile Compounding Pharmacies Market Regional Analysis
6.2 North America Sterile Compounding Pharmacies Market Revenue 2019-2028 (US$ Million)
6.3 North America Sterile Compounding Pharmacies Market Forecast Analysis
7. North America Sterile Compounding Pharmacies Market Analysis – by Product
7.1 Injectable Drugs and Infusions
- 7.1.1 Overview
- 7.1.2 Injectable Drugs and Infusions: North America Sterile Compounding Pharmacies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Sterile Compounding Pharmacies Market Analysis – by Route of Administration
8.1 Intravenous
- 8.1.1 Overview
- 8.1.2 Intravenous: North America Sterile Compounding Pharmacies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Intramuscular
- 8.2.1 Overview
- 8.2.2 Intramuscular: North America Sterile Compounding Pharmacies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Subcutaneous
- 8.3.1 Overview
- 8.3.2 Subcutaneous : North America Sterile Compounding Pharmacies Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Sterile Compounding Pharmacies Market – North America Analysis
9.1 Overview
9.2 North America- 9.2.1 North America Sterile Compounding Pharmacies Market Breakdown, by Key Country, 2022 and 2028 (%)
- 9.2.1.1 North America Sterile Compounding Pharmacies Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 US: North America Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 US: North America Sterile Compounding Pharmacies Market Breakdown, by Product
- 9.2.1.1.2 US: North America Sterile Compounding Pharmacies Market Breakdown, by Route of Administration
- 9.2.1.2 Canada: North America Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Canada: North America Sterile Compounding Pharmacies Market Breakdown, by Product
- 9.2.1.2.2 Canada: North America Sterile Compounding Pharmacies Market Breakdown, by Route of Administration
- 9.2.1.3 Mexico : North America Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Mexico : North America Sterile Compounding Pharmacies Market Breakdown, by Product
- 9.2.1.3.2 Mexico : North America Sterile Compounding Pharmacies Market Breakdown, by Route of Administration
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Avella Specialty Pharmacy
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 B. Braun Melsungen AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Fagron, Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Fresenius Kabi AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pace Pharmacy
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pavilion Compounding Pharmacy, LLC.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Pencol Compounding Pharmacy
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 PharMEDium Healthcare Holdings, Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 SandsRx
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Triangle Compounding Pharmacy
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
